BackBlueprint Medicines Overview
Blueprint Medicines Corp

Blueprint Medicines Target Price

Analysts' 12-month price predictions for BPMC.

Share Price

$114.98

Average Target Price

$115.250.2% upside

4 analysts in the last 4 months

High: $135 | Low: $97

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-07-08OppenheimerMatthew Biegler$1258.7% upsideOpen
2024-05-06Leerink PartnersAndrew Berens$9715.6% downsideOpen
2024-05-03Raymond JamesChristopher Raymond$1049.5% downsideOpen
2024-05-03H.C. WainwrightAndrew Fein$13517.4% upsideOpen
2022-12-14Needham$6047.8% downsideOpen
2022-11-02H.C. WainwrightAndrew Fein$7039.1% downsideOpen
2022-09-06OppenheimerMatthew Biegler$9021.7% downsideOpen
2022-08-17Wells FargoDerek Archila$4164.3% downsideOpen
2022-05-18Piper SandlerChristopher Raymond$6543.5% downsideOpen
2022-02-01Morgan StanleyMichael Ulz$9220% downsideOpen
2022-01-03GuggenheimMichael Schmidt$1226.1% upsideOpen
2021-11-09Raymond JamesDane Leone$13315.7% upsideOpen
2021-07-29Goldman SachsSalveen Richter$14727.8% upsideOpen
2021-06-17Canaccord GenuityArlinda Lee$1204.4% upsideOpen